LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.

LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.

Item
http://www.wikidata.org/entity/Q53338722
Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its managementHematopoietic Id Deletion Triggers Endomyocardial Fibrotic and Vascular Defects in the Adult Heart.Thrombospondin-1: multiple paths to inflammation.Biological Significance of Local TGF-β Activation in Liver Diseases.Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model.LSKL peptide alleviates subarachnoid fibrosis and hydrocephalus by inhibiting TSP1-mediated TGF-β1 signaling activity following subarachnoid hemorrhage in rats.Myofibroblast differentiation and survival in fibrotic disease.MicroRNA21 promotes interstitial fibrosis via targeting DDAH1: a potential role in renal fibrosis.Localization of thrombospondin-1 and myofibroblasts during corneal wound repair.Thrombospondin immune regulation and the kidney.Thrombospondins: A Role in Cardiovascular Disease.Effect of dietary Schizochytrium microalga oil on selected markers of low-grade inflammation in rats.[Role of thrombospondin-1 in the development of kidney diseases].Thrombospondin-1 short hairpin RNA suppresses tubulointerstitial fibrosis in the kidney of ureteral obstruction by ameliorating peritubular capillary injury.The Roles of Thrombospondins in Hemorrhagic Stroke.Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.
P2860

LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.

Item
http://www.wikidata.org/entity/Q53338722
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
LSKL, a peptide antagonist of ...... ilateral ureteral obstruction.
@en
LSKL, a peptide antagonist of ...... ilateral ureteral obstruction.
@nl
type
label
LSKL, a peptide antagonist of ...... ilateral ureteral obstruction.
@en
LSKL, a peptide antagonist of ...... ilateral ureteral obstruction.
@nl
prefLabel
LSKL, a peptide antagonist of ...... ilateral ureteral obstruction.
@en
LSKL, a peptide antagonist of ...... ilateral ureteral obstruction.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
LSKL, a peptide antagonist of ...... ilateral ureteral obstruction.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698